Effects  ||| S:0 E:8 ||| NNS
of  ||| S:8 E:11 ||| IN
chronic  ||| S:11 E:19 ||| JJ
acetazolamide  ||| S:19 E:33 ||| JJ
administration  ||| S:33 E:48 ||| NN
on  ||| S:48 E:51 ||| IN
gas  ||| S:51 E:55 ||| NN
exchange  ||| S:55 E:64 ||| NN
and  ||| S:64 E:68 ||| CC
acid-base  ||| S:68 E:78 ||| JJ
control  ||| S:78 E:86 ||| NN
in  ||| S:86 E:89 ||| IN
pulmonary  ||| S:89 E:99 ||| JJ
circulation  ||| S:99 E:111 ||| NN
in  ||| S:111 E:114 ||| IN
exercising  ||| S:114 E:125 ||| FW
horses  ||| S:125 E:132 ||| FW
Carbonic  ||| S:132 E:141 ||| FW
anhydrase  ||| S:141 E:151 ||| FW
( ||| S:151 E:152 ||| -LRB-
CA ||| S:152 E:154 ||| NNP
)  ||| S:154 E:156 ||| -RRB-
catalyses  ||| S:156 E:166 ||| VBZ
the  ||| S:166 E:170 ||| DT
hydration ||| S:170 E:179 ||| JJ
/ ||| S:179 E:180 ||| CD
dehydration  ||| S:180 E:192 ||| JJ
reaction  ||| S:192 E:201 ||| NN
of  ||| S:201 E:204 ||| IN
CO ||| S:204 E:206 ||| NNP
( ||| S:206 E:207 ||| -LRB-
2 ||| S:207 E:208 ||| LS
)  ||| S:208 E:210 ||| -RRB-
and  ||| S:210 E:214 ||| CC
increases  ||| S:214 E:224 ||| VBZ
the  ||| S:224 E:228 ||| DT
rate  ||| S:228 E:233 ||| NN
of  ||| S:233 E:236 ||| IN
Cl ||| S:236 E:238 ||| NNP
( ||| S:238 E:239 ||| -LRB-
- ||| S:239 E:240 ||| NNP
)  ||| S:240 E:242 ||| -RRB-
and  ||| S:242 E:246 ||| CC
HCO ||| S:246 E:249 ||| NNP
( ||| S:249 E:250 ||| -LRB-
3 ||| S:250 E:251 ||| LS
) ||| S:251 E:252 ||| -RRB-
( ||| S:252 E:253 ||| -LRB-
- ||| S:253 E:254 ||| NNP
)  ||| S:254 E:256 ||| -RRB-
exchange  ||| S:256 E:265 ||| NN
between  ||| S:265 E:273 ||| IN
the  ||| S:273 E:277 ||| DT
erythrocytes  ||| S:277 E:290 ||| NN
and  ||| S:290 E:294 ||| CC
plasma ||| S:294 E:300 ||| NN
.  ||| S:300 E:302 ||| .
Therefore ||| S:302 E:311 ||| RB
,  ||| S:311 E:313 ||| ,
chronic  ||| S:313 E:321 ||| JJ
inhibition  ||| S:321 E:332 ||| NN
of  ||| S:332 E:335 ||| IN
CA  ||| S:335 E:338 ||| NNP
has  ||| S:338 E:342 ||| VBZ
a  ||| S:342 E:344 ||| DT
potential  ||| S:344 E:354 ||| JJ
to  ||| S:354 E:357 ||| TO
attenuate  ||| S:357 E:367 ||| VB
CO ||| S:367 E:369 ||| NNP
( ||| S:369 E:370 ||| -LRB-
2 ||| S:370 E:371 ||| LS
)  ||| S:371 E:373 ||| -RRB-
output  ||| S:373 E:380 ||| NN
and  ||| S:380 E:384 ||| CC
induce  ||| S:384 E:391 ||| VB
greater  ||| S:391 E:399 ||| JJR
metabolic  ||| S:399 E:409 ||| NNS
and  ||| S:409 E:413 ||| CC
respiratory  ||| S:413 E:425 ||| JJ
acidosis  ||| S:425 E:434 ||| NN
in  ||| S:434 E:437 ||| IN
exercising  ||| S:437 E:448 ||| VBG
horses ||| S:448 E:454 ||| NNS
.  ||| S:454 E:456 ||| .
To  ||| S:456 E:459 ||| TO
determine  ||| S:459 E:469 ||| VB
the  ||| S:469 E:473 ||| DT
effects  ||| S:473 E:481 ||| NNS
of  ||| S:481 E:484 ||| IN
Carbonic  ||| S:484 E:493 ||| NNP
anhydrase  ||| S:493 E:503 ||| VBD
inhibition  ||| S:503 E:514 ||| VBN
on  ||| S:514 E:517 ||| IN
CO ||| S:517 E:519 ||| NNP
( ||| S:519 E:520 ||| -LRB-
2 ||| S:520 E:521 ||| LS
)  ||| S:521 E:523 ||| -RRB-
output  ||| S:523 E:530 ||| NN
and  ||| S:530 E:534 ||| CC
ionic  ||| S:534 E:540 ||| JJ
exchange  ||| S:540 E:549 ||| NN
between  ||| S:549 E:557 ||| IN
erythrocytes  ||| S:557 E:570 ||| NN
and  ||| S:570 E:574 ||| CC
plasma  ||| S:574 E:581 ||| NN
and  ||| S:581 E:585 ||| CC
their  ||| S:585 E:591 ||| PRP$
influence  ||| S:591 E:601 ||| NN
on  ||| S:601 E:604 ||| IN
acid-base  ||| S:604 E:614 ||| JJ
balance  ||| S:614 E:622 ||| NN
in  ||| S:622 E:625 ||| IN
the  ||| S:625 E:629 ||| DT
pulmonary  ||| S:629 E:639 ||| JJ
circulation  ||| S:639 E:651 ||| NN
( ||| S:651 E:652 ||| -LRB-
across  ||| S:652 E:659 ||| IN
the  ||| S:659 E:663 ||| DT
lung ||| S:663 E:667 ||| NN
)  ||| S:667 E:669 ||| -RRB-
in  ||| S:669 E:672 ||| IN
exercising  ||| S:672 E:683 ||| VBG
horses  ||| S:683 E:690 ||| NNS
with  ||| S:690 E:695 ||| IN
and  ||| S:695 E:699 ||| CC
without  ||| S:699 E:707 ||| IN
CA  ||| S:707 E:710 ||| NNP
inhibition ||| S:710 E:720 ||| NN
.  ||| S:720 E:722 ||| .
Six  ||| S:722 E:726 ||| CD
horses  ||| S:726 E:733 ||| NNS
were  ||| S:733 E:738 ||| VBD
exercised  ||| S:738 E:748 ||| VBN
to  ||| S:748 E:751 ||| TO
exhaustion  ||| S:751 E:762 ||| VB
on  ||| S:762 E:765 ||| IN
a  ||| S:765 E:767 ||| DT
treadmill  ||| S:767 E:777 ||| NN
without  ||| S:777 E:785 ||| IN
( ||| S:785 E:786 ||| -LRB-
Con ||| S:786 E:789 ||| NNP
)  ||| S:789 E:791 ||| -RRB-
and  ||| S:791 E:795 ||| CC
with  ||| S:795 E:800 ||| IN
CA  ||| S:800 E:803 ||| NNP
inhibition  ||| S:803 E:814 ||| NNS
( ||| S:814 E:815 ||| -LRB-
AczTr ||| S:815 E:820 ||| NNP
) ||| S:820 E:821 ||| -RRB-
.  ||| S:821 E:823 ||| .
CA  ||| S:823 E:826 ||| MD
inhibition  ||| S:826 E:837 ||| RB
was  ||| S:837 E:841 ||| VBD
achieved  ||| S:841 E:850 ||| VBN
with  ||| S:850 E:855 ||| IN
administration  ||| S:855 E:870 ||| NN
of  ||| S:870 E:873 ||| IN
acetazolamide  ||| S:873 E:887 ||| NNS
( ||| S:887 E:888 ||| -LRB-
10  ||| S:888 E:891 ||| CD
mg ||| S:891 E:893 ||| CD
/ ||| S:893 E:894 ||| CD
kg  ||| S:894 E:897 ||| CD
bwt  ||| S:897 E:901 ||| CD
t.i.d.  ||| S:901 E:908 ||| CD
for  ||| S:908 E:912 ||| IN
3  ||| S:912 E:914 ||| CD
days  ||| S:914 E:919 ||| NNS
and  ||| S:919 E:923 ||| CC
30  ||| S:923 E:926 ||| CD
mg ||| S:926 E:928 ||| CD
/ ||| S:928 E:929 ||| CD
kg  ||| S:929 E:932 ||| JJ
bwt  ||| S:932 E:936 ||| NN
before  ||| S:936 E:943 ||| IN
exercise ||| S:943 E:951 ||| NN
) ||| S:951 E:952 ||| -RRB-
.  ||| S:952 E:954 ||| .
Arterial ||| S:954 E:962 ||| NNP
,  ||| S:962 E:964 ||| ,
mixed  ||| S:964 E:970 ||| JJ
venous  ||| S:970 E:977 ||| JJ
blood  ||| S:977 E:983 ||| NN
and  ||| S:983 E:987 ||| CC
CO ||| S:987 E:989 ||| NNP
( ||| S:989 E:990 ||| -LRB-
2 ||| S:990 E:991 ||| LS
)  ||| S:991 E:993 ||| -RRB-
output  ||| S:993 E:1000 ||| NN
were  ||| S:1000 E:1005 ||| VBD
sampled  ||| S:1005 E:1013 ||| VBN
at  ||| S:1013 E:1016 ||| IN
rest  ||| S:1016 E:1021 ||| NN
and  ||| S:1021 E:1025 ||| CC
during  ||| S:1025 E:1032 ||| IN
exercise ||| S:1032 E:1040 ||| NN
.  ||| S:1040 E:1042 ||| .
An  ||| S:1042 E:1045 ||| DT
integrated  ||| S:1045 E:1056 ||| JJ
physicochemical  ||| S:1056 E:1072 ||| JJ
systems  ||| S:1072 E:1080 ||| NNS
approach  ||| S:1080 E:1089 ||| NN
was  ||| S:1089 E:1093 ||| VBD
used  ||| S:1093 E:1098 ||| VBN
to  ||| S:1098 E:1101 ||| TO
describe  ||| S:1101 E:1110 ||| VB
acid  ||| S:1110 E:1115 ||| JJ
base  ||| S:1115 E:1120 ||| NN
changes ||| S:1120 E:1127 ||| NNS
.  ||| S:1127 E:1129 ||| .
AczTr  ||| S:1129 E:1135 ||| NNP
decreased  ||| S:1135 E:1145 ||| VBD
the  ||| S:1145 E:1149 ||| DT
duration  ||| S:1149 E:1158 ||| NN
of  ||| S:1158 E:1161 ||| IN
exercise  ||| S:1161 E:1170 ||| NN
by  ||| S:1170 E:1173 ||| IN
45 ||| S:1173 E:1175 ||| CD
%  ||| S:1175 E:1177 ||| NN
( ||| S:1177 E:1178 ||| -LRB-
P  ||| S:1178 E:1180 ||| NNP
< ||| S:1180 E:1182 ||| SYM
0.0001 ||| S:1182 E:1188 ||| NNP
) ||| S:1188 E:1189 ||| -RRB-
.  ||| S:1189 E:1191 ||| .
During  ||| S:1191 E:1198 ||| IN
the  ||| S:1198 E:1202 ||| DT
transition  ||| S:1202 E:1213 ||| NN
from  ||| S:1213 E:1218 ||| IN
rest  ||| S:1218 E:1223 ||| NN
to  ||| S:1223 E:1226 ||| TO
exercise  ||| S:1226 E:1235 ||| VB
CO ||| S:1235 E:1237 ||| NNP
( ||| S:1237 E:1238 ||| -LRB-
2 ||| S:1238 E:1239 ||| LS
)  ||| S:1239 E:1241 ||| -RRB-
output  ||| S:1241 E:1248 ||| NN
was  ||| S:1248 E:1252 ||| VBD
lower  ||| S:1252 E:1258 ||| JJR
in  ||| S:1258 E:1261 ||| IN
AczTr  ||| S:1261 E:1267 ||| NNP
( ||| S:1267 E:1268 ||| -LRB-
P  ||| S:1268 E:1270 ||| NNP
< ||| S:1270 E:1272 ||| SYM
0.0001 ||| S:1272 E:1278 ||| NNP
) ||| S:1278 E:1279 ||| -RRB-
.  ||| S:1279 E:1281 ||| .
Arterial  ||| S:1281 E:1290 ||| NNP
PCO ||| S:1290 E:1293 ||| NNP
( ||| S:1293 E:1294 ||| -LRB-
2 ||| S:1294 E:1295 ||| LS
)  ||| S:1295 E:1297 ||| -RRB-
( ||| S:1297 E:1298 ||| -LRB-
P  ||| S:1298 E:1300 ||| NNP
< ||| S:1300 E:1302 ||| SYM
0.0001 ||| S:1302 E:1308 ||| NNP
;  ||| S:1308 E:1310 ||| :
mean  ||| S:1310 E:1315 ||| VB
±  ||| S:1315 E:1317 ||| CD
s.e.  ||| S:1317 E:1322 ||| CD
71  ||| S:1322 E:1325 ||| CD
±  ||| S:1325 E:1327 ||| CD
2  ||| S:1327 E:1329 ||| CD
mmHg  ||| S:1329 E:1334 ||| JJ
AczTr ||| S:1334 E:1339 ||| NN
,  ||| S:1339 E:1341 ||| ,
46  ||| S:1341 E:1344 ||| CD
±  ||| S:1344 E:1346 ||| CD
2  ||| S:1346 E:1348 ||| CD
mmHg  ||| S:1348 E:1353 ||| JJ
Con ||| S:1353 E:1356 ||| NN
)  ||| S:1356 E:1358 ||| -RRB-
was  ||| S:1358 E:1362 ||| VBD
higher ||| S:1362 E:1368 ||| JJR
,  ||| S:1368 E:1370 ||| ,
whereas  ||| S:1370 E:1378 ||| FW
hydrogen  ||| S:1378 E:1387 ||| FW
ion  ||| S:1387 E:1391 ||| FW
( ||| S:1391 E:1392 ||| -LRB-
P  ||| S:1392 E:1394 ||| NN
=  ||| S:1394 E:1396 ||| SYM
0.01 ||| S:1396 E:1400 ||| CD
;  ||| S:1400 E:1402 ||| :
12.8  ||| S:1402 E:1407 ||| CD
±  ||| S:1407 E:1409 ||| CD
0.6  ||| S:1409 E:1413 ||| CD
nEq ||| S:1413 E:1416 ||| JJ
/ ||| S:1416 E:1417 ||| CD
l  ||| S:1417 E:1419 ||| JJ
AczTr ||| S:1419 E:1424 ||| NN
,  ||| S:1424 E:1426 ||| ,
15.5  ||| S:1426 E:1431 ||| CD
±  ||| S:1431 E:1433 ||| CD
0.6  ||| S:1433 E:1437 ||| CD
nEq ||| S:1437 E:1440 ||| JJ
/ ||| S:1440 E:1441 ||| CD
l  ||| S:1441 E:1443 ||| JJ
Con ||| S:1443 E:1446 ||| NN
)  ||| S:1446 E:1448 ||| -RRB-
and  ||| S:1448 E:1452 ||| CC
bicarbonate  ||| S:1452 E:1464 ||| NNS
( ||| S:1464 E:1465 ||| -LRB-
P  ||| S:1465 E:1467 ||| NN
=  ||| S:1467 E:1469 ||| SYM
0.007 ||| S:1469 E:1474 ||| CD
;  ||| S:1474 E:1476 ||| :
5.5  ||| S:1476 E:1480 ||| CD
±  ||| S:1480 E:1482 ||| CD
0.7  ||| S:1482 E:1486 ||| CD
mEq ||| S:1486 E:1489 ||| JJ
/ ||| S:1489 E:1490 ||| CD
l  ||| S:1490 E:1492 ||| JJ
AczTr ||| S:1492 E:1497 ||| NN
,  ||| S:1497 E:1499 ||| ,
10.1  ||| S:1499 E:1504 ||| CD
±  ||| S:1504 E:1506 ||| CD
1.3  ||| S:1506 E:1510 ||| CD
mEq ||| S:1510 E:1513 ||| JJ
/ ||| S:1513 E:1514 ||| CD
l  ||| S:1514 E:1516 ||| JJ
Con ||| S:1516 E:1519 ||| NN
)  ||| S:1519 E:1521 ||| -RRB-
differences  ||| S:1521 E:1533 ||| NNS
across  ||| S:1533 E:1540 ||| IN
the  ||| S:1540 E:1544 ||| DT
lung  ||| S:1544 E:1549 ||| NN
were  ||| S:1549 E:1554 ||| VBD
lower  ||| S:1554 E:1560 ||| JJR
in  ||| S:1560 E:1563 ||| IN
AczTr  ||| S:1563 E:1569 ||| JJ
compared  ||| S:1569 E:1578 ||| VBN
to  ||| S:1578 E:1581 ||| TO
Con ||| S:1581 E:1584 ||| NN
.  ||| S:1584 E:1586 ||| .
No  ||| S:1586 E:1589 ||| DT
difference  ||| S:1589 E:1600 ||| NN
was  ||| S:1600 E:1604 ||| VBD
observed  ||| S:1604 E:1613 ||| VBN
in  ||| S:1613 E:1616 ||| IN
weak  ||| S:1616 E:1621 ||| JJ
electrolytes  ||| S:1621 E:1634 ||| NN
across  ||| S:1634 E:1641 ||| IN
the  ||| S:1641 E:1645 ||| DT
lung ||| S:1645 E:1649 ||| NN
.  ||| S:1649 E:1651 ||| .
Strong  ||| S:1651 E:1658 ||| JJ
ion  ||| S:1658 E:1662 ||| JJ
difference  ||| S:1662 E:1673 ||| NN
across  ||| S:1673 E:1680 ||| IN
the  ||| S:1680 E:1684 ||| DT
lung  ||| S:1684 E:1689 ||| NN
was  ||| S:1689 E:1693 ||| VBD
lower  ||| S:1693 E:1699 ||| JJR
in  ||| S:1699 E:1702 ||| IN
AczTr  ||| S:1702 E:1708 ||| NNP
( ||| S:1708 E:1709 ||| -LRB-
P  ||| S:1709 E:1711 ||| NN
=  ||| S:1711 E:1713 ||| SYM
0.0003 ||| S:1713 E:1719 ||| CD
;  ||| S:1719 E:1721 ||| :
4.9  ||| S:1721 E:1725 ||| CD
±  ||| S:1725 E:1727 ||| CD
0.8  ||| S:1727 E:1731 ||| CD
mEq  ||| S:1731 E:1735 ||| JJ
AczTr ||| S:1735 E:1740 ||| NN
,  ||| S:1740 E:1742 ||| ,
7.5  ||| S:1742 E:1746 ||| CD
±  ||| S:1746 E:1748 ||| CD
1.2  ||| S:1748 E:1752 ||| CD
mEq  ||| S:1752 E:1756 ||| JJ
Con ||| S:1756 E:1759 ||| NN
) ||| S:1759 E:1760 ||| -RRB-
,  ||| S:1760 E:1762 ||| ,
which  ||| S:1762 E:1768 ||| WDT
was  ||| S:1768 E:1772 ||| VBD
affected  ||| S:1772 E:1781 ||| VBN
by  ||| S:1781 E:1784 ||| IN
strong  ||| S:1784 E:1791 ||| JJ
ion  ||| S:1791 E:1795 ||| JJ
changes  ||| S:1795 E:1803 ||| NNS
across  ||| S:1803 E:1810 ||| IN
the  ||| S:1810 E:1814 ||| DT
lung  ||| S:1814 E:1819 ||| NN
with  ||| S:1819 E:1824 ||| IN
exception  ||| S:1824 E:1834 ||| NN
of  ||| S:1834 E:1837 ||| IN
lactate ||| S:1837 E:1844 ||| NN
.  ||| S:1844 E:1846 ||| .
CO ||| S:1846 E:1848 ||| NNP
( ||| S:1848 E:1849 ||| -LRB-
2 ||| S:1849 E:1850 ||| LS
)  ||| S:1850 E:1852 ||| -RRB-
and  ||| S:1852 E:1856 ||| CC
chloride  ||| S:1856 E:1865 ||| JJ
changes  ||| S:1865 E:1873 ||| NNS
in  ||| S:1873 E:1876 ||| IN
erythrocytes  ||| S:1876 E:1889 ||| NN
across  ||| S:1889 E:1896 ||| IN
the  ||| S:1896 E:1900 ||| DT
lung  ||| S:1900 E:1905 ||| NN
seem  ||| S:1905 E:1910 ||| VBP
to  ||| S:1910 E:1913 ||| TO
be  ||| S:1913 E:1916 ||| VB
the  ||| S:1916 E:1920 ||| DT
major  ||| S:1920 E:1926 ||| JJ
contributors  ||| S:1926 E:1939 ||| NNS
to  ||| S:1939 E:1942 ||| TO
acid-base  ||| S:1942 E:1952 ||| JJ
and  ||| S:1952 E:1956 ||| CC
ions  ||| S:1956 E:1961 ||| JJ
balance  ||| S:1961 E:1969 ||| NN
in  ||| S:1969 E:1972 ||| IN
pulmonary  ||| S:1972 E:1982 ||| JJ
circulation  ||| S:1982 E:1994 ||| NN
in  ||| S:1994 E:1997 ||| IN
exercising  ||| S:1997 E:2008 ||| VBG
horses ||| S:2008 E:2014 ||| NNS
.  ||| S:2014 E:2016 ||| .
